278 related articles for article (PubMed ID: 27484511)
21. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549.
Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A
Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574
[TBL] [Abstract][Full Text] [Related]
23. Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells.
Mapoung S; Pitchakarn P; Yodkeeree S; Ovatlarnporn C; Sakorn N; Limtrakul P
Chem Biol Interact; 2016 Jan; 244():140-8. PubMed ID: 26689174
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
25. BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species.
Wang J; Liu L; Cen J; Ji B
Chem Biol Interact; 2015 Sep; 239():139-45. PubMed ID: 26169035
[TBL] [Abstract][Full Text] [Related]
26. Reversal of mdr1-mediated multidrug resistance in human leukemia cells by a new spin-labeled derivative of podophyllotoxin.
Qi SN; Song LJ; Chen Y; Jing YX
Pharmazie; 2010 Feb; 65(2):117-21. PubMed ID: 20225656
[TBL] [Abstract][Full Text] [Related]
27. OAMDP, a novel podophyllotoxin derivative, induces apoptosis, cell cycle arrest and autophagy in hepatoma HepG2 cells.
Ren J; Liu Y; Li L; Zhao Y; Li Z; Wu C; Chen L; Hu K
Cell Biol Int; 2018 Feb; 42(2):194-204. PubMed ID: 29052919
[TBL] [Abstract][Full Text] [Related]
28. The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway.
Hseu YC; Lee MS; Wu CR; Cho HJ; Lin KY; Lai GH; Wang SY; Kuo YH; Kumar KJ; Yang HL
J Agric Food Chem; 2012 Mar; 60(9):2385-97. PubMed ID: 22324429
[TBL] [Abstract][Full Text] [Related]
29. AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species.
Zhang LH; Jia YL; Lin XX; Zhang HQ; Dong XW; Zhao JM; Shen J; Shen HJ; Li FF; Yan XF; Li W; Zhao YQ; Xie QM
Biochim Biophys Acta; 2013 Aug; 1830(8):4148-59. PubMed ID: 23583729
[TBL] [Abstract][Full Text] [Related]
30. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
31. L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line.
Chen H; Wang J; Zhang J; Wang Y; Cao B; Bai S; Yu PF; Bi W; Xie W
Biol Pharm Bull; 2009 Apr; 32(4):609-13. PubMed ID: 19336892
[TBL] [Abstract][Full Text] [Related]
32. [Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells].
Ye J; Zheng Y; Liu D
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):761-5. PubMed ID: 19624024
[TBL] [Abstract][Full Text] [Related]
33. Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells.
Chen FY; Cao LF; Wan HX; Zhang MY; Cai JY; Shen LJ; Zhong JH; Zhong H
Mol Med Rep; 2015 Jan; 11(1):341-8. PubMed ID: 25339540
[TBL] [Abstract][Full Text] [Related]
34. Annosquacin B induces mitochondrial apoptosis in multidrug resistant human breast cancer cell line MCF-7/ADR through selectively modulating MAPKs pathways.
Yuan F; Bai G; Miao Y; Chen Y; Li X; Chen J
Pharm Biol; 2016 Dec; 54(12):3040-3045. PubMed ID: 27450387
[TBL] [Abstract][Full Text] [Related]
35. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
36. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.
Han HW; Qiu HY; Hu C; Sun WX; Yang RW; Qi JL; Wang XM; Lu GH; Yang YH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3237-3242. PubMed ID: 27262599
[TBL] [Abstract][Full Text] [Related]
38. Involvement of oxidative stress in taxol-induced apoptosis in chronic myelogenous leukemia K562 cells.
Meshkini A; Yazdanparast R
Exp Toxicol Pathol; 2012 May; 64(4):357-65. PubMed ID: 21074392
[TBL] [Abstract][Full Text] [Related]
39. Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells.
Cai Y; Lu J; Miao Z; Lin L; Ding J
Cancer Biol Ther; 2007 Nov; 6(11):1794-9. PubMed ID: 18032928
[TBL] [Abstract][Full Text] [Related]
40. GMZ-1 is a podophyllotoxin derivative that suppresses growth and induces apoptosis in adriamycin-resistant K562/A02 cells through modulation of MDR1 expression.
Cao B; Yang S; Li W; Chen H; Chen Y; Liu Y; Liu B
Mol Med Rep; 2018 Jan; 17(1):474-478. PubMed ID: 29115592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
